CIK 0001162194 · Accelerated filer
STANDARD BIOTOOLS INC.
Sign in to watch- Ticker
- LAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770513190
- Phone
- 6502666000
- Business address
- 50 MILK STREET, 10TH FLOOR, BOSTON, MA, 02109
- Former names
- FLUIDIGM CORP
- 4 Open-market buy Director bought 1,069,562 shares at an average $1.61 ($1,718,801)
- 4 Open-market buy Director bought 1,200,000 shares at an average $1.62 ($1,948,680)
- 4 Grant or award Director acquired 1,588 shares (grant or award)
- 4 Grant or award Director acquired 43,128 shares (grant or award)
- 4 Grant or award Director acquired 43,128 shares (grant or award)
- 4 Grant or award Director acquired 43,128 shares (grant or award)
- 4 Grant or award Director acquired 43,128 shares (grant or award)
- 4 Grant or award Director acquired 43,128 shares (grant or award)
- 4 Grant or award Director acquired 43,128 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Other disposition Director disposed of 1,200,000 shares (other)
- 4 Open-market buy Director bought 100,000 shares at $2.60 ($260,000)
- 4 Open-market buy Director bought 600,000 shares at an average $2.57 ($1,541,795)
- 4 Grant or award President & CEO acquired 1,000,000 shares (grant or award)
- 4 Grant or award SVP & Chief Financial Officer acquired 300,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 333,333 shares (grant or award)
- 4 Open-market buy Director bought 1,352,072 shares at an average $2.56 ($3,455,544)
- 4 Shares withheld for taxes SVP & Chief Financial Officer gave up 18,779 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 102,564 shares (to pay taxes)
- 4 Grant or award President & CEO acquired 221,132 shares (grant or award)
Page 5 of 46 · 902 filings